SCHEMBL15034153

SCHEMBL15034153

CC1(C)CN(C(=O)c2cccc(C3CC3)c2)CCN1C(=O)c1ncn(-c2ccccc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 3/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.39
CFTR P13569 1/20 0.38
HPGD P15428 2/20 0.38
MAPT P10636 6/20 0.37
USP2 O75604 1/20 0.37
MAPK1 P28482 1/20 0.37
MGLL Q99685 2/20 0.36
TP53 P04637 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TRPV6 Q9H1D0 1/20 0.35
RECQL P46063 1/20 0.35
PROKR1 Q8TCW9 2/20 0.35
NOTUM Q6P988 1/20 0.35
POLB P06746 1/20 0.35
PARP14 Q460N5 1/20 0.35
PARP10 Q53GL7 1/20 0.35
USP30 Q70CQ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15034161 0.96 HPGD (0.40) ALDH1A1KDM4ELMNATSHRCFTR
SCHEMBL15034172 0.96 HPGD (0.40) ALDH1A1KDM4ELMNATSHRCFTR
SCHEMBL15034134 0.88 CFTR (0.44) ALDH1A1TSHRCFTRHPGDMAPT
SCHEMBL15034138 0.87 HPGD (0.44) ALDH1A1LMNATSHRCFTRHPGD
SCHEMBL15034131 0.86 CYP3A4 (0.48) ALDH1A1TSHRHPGDUSP2MAPK1
SCHEMBL15020006 0.86 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDMAPTTP53
SCHEMBL15020047 0.85 HPGD (0.41) ALDH1A1LMNATSHRCFTRHPGD
SCHEMBL15034147 0.85 HPGD (0.41) ALDH1A1LMNATSHRCFTRHPGD
SCHEMBL15034139 0.85 ALDH1A1 (0.47) ALDH1A1CFTRHPGDMAPTTP53
SCHEMBL15034152 0.84 MAPT (0.39) ALDH1A1LMNATSHRCFTRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883789-B2 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-11 US disclosed
US-8883789-B2 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-11 US disclosed
US-20130158042-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed
US-20130158042-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158042-A1 NOVEL COMPOUNDS GRM5, GRIK5, GRM1 ALDH1A1 3952/4885KDM4E 1242/4885LMNA 4835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.